JCEM:体重指数增加与抗穆勒激素降低有关

2020-08-07 MedSci原创 MedSci原创

BMI(而非BSA)与AMH降低有关;这些数据不支持血液稀释在介导体重增加和AMH降低之间关联中的作用。卵泡产生的AMH降低可能是BMI升高导致AMH降低的原因。

对于患有和不患有多囊卵巢综合征(PCOS)的女性,体重指数(BMI)是否会以及如何影响抗穆勒激素(AMH)一直存在争议。了解BMI-AMH之间的关系对实验室检查结果的临床解释具有关键意义,并可能阐明潜在的卵巢生理学机制。近日,内分泌和代谢性疾病领域权威杂志Journal of Clinical Endocrinology & Metabolism上发表了一篇研究文章,该研究旨在检验一个假设:(1)BMI与PCOS和排卵对照(OVA)女性AMH降低有关,(2)稀释效应不能解释AMH水平的降低。

该研究为多中心队列研究,参加者来自两个临床人群25-40岁年龄段的女性:包含640名PCOS,921名排卵对照(OVA)者。该研究的主要观察指标为卵巢储备指数:AMH;窦卵泡计数(AFC);以及AMH与AFC的比值(AMH/AFC)。

在多因素回归模型中调整了年龄、种族、吸烟和区域后,在这两个队列中,BMI和腰围(WC)的增加与AMH和AMH/AFC的减少有关。BMI的增加与PCOS患者AFC的减少有关,但与OVA无关。加入人体表面积(BSA),与BMI不一样,其与血浆体积成正比,以探究人体大小对AMH浓度潜在的稀释作用。在控制了BSA之后,在两个队列中BMI都保留了与AMH之间的独立关联。BSA与AMH之间不再具有关联。

在调整后的分析中,BMI(而非BSA)与AMH降低有关;这些数据不支持血液稀释在介导体重增加和AMH降低之间关联中的作用。卵泡产生的AMH降低可能是BMI升高导致AMH降低的原因。

原始出处:

Eleni Greenwood Jaswa,et al.Increased body mass index is associated with a non-dilutional reduction in antimullerian hormone.JCEM.2020.https://doi.org/10.1210/clinem/dgaa436

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1777968, encodeId=8cab1e7796872, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Thu Dec 17 08:00:35 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063350, encodeId=81f6206335016, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Dec 29 08:00:35 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736333, encodeId=4ef71e36333f1, content=<a href='/topic/show?id=451c55591a1' target=_blank style='color:#2F92EE;'>#抗穆勒激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55591, encryptionId=451c55591a1, topicName=抗穆勒激素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e734130559, createdName=xiay994464, createdTime=Fri Oct 23 21:00:35 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885175, encodeId=767e8851e5ec, content=<a href='/topic/show?id=9e7f26683a4' target=_blank style='color:#2F92EE;'>#体重#</a>与很多疾病都有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26683, encryptionId=9e7f26683a4, topicName=体重)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Sep 14 15:42:00 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807521, encodeId=761880e521b2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9055410320, createdName=ms5000000166877329, createdTime=Tue Aug 11 18:43:59 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806782, encodeId=f1b6806e82bb, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Aug 07 13:22:39 CST 2020, time=2020-08-07, status=1, ipAttribution=)]
    2020-12-17 smallant2015
  2. [GetPortalCommentsPageByObjectIdResponse(id=1777968, encodeId=8cab1e7796872, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Thu Dec 17 08:00:35 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063350, encodeId=81f6206335016, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Dec 29 08:00:35 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736333, encodeId=4ef71e36333f1, content=<a href='/topic/show?id=451c55591a1' target=_blank style='color:#2F92EE;'>#抗穆勒激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55591, encryptionId=451c55591a1, topicName=抗穆勒激素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e734130559, createdName=xiay994464, createdTime=Fri Oct 23 21:00:35 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885175, encodeId=767e8851e5ec, content=<a href='/topic/show?id=9e7f26683a4' target=_blank style='color:#2F92EE;'>#体重#</a>与很多疾病都有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26683, encryptionId=9e7f26683a4, topicName=体重)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Sep 14 15:42:00 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807521, encodeId=761880e521b2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9055410320, createdName=ms5000000166877329, createdTime=Tue Aug 11 18:43:59 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806782, encodeId=f1b6806e82bb, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Aug 07 13:22:39 CST 2020, time=2020-08-07, status=1, ipAttribution=)]
    2020-12-29 achengzhao
  3. [GetPortalCommentsPageByObjectIdResponse(id=1777968, encodeId=8cab1e7796872, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Thu Dec 17 08:00:35 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063350, encodeId=81f6206335016, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Dec 29 08:00:35 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736333, encodeId=4ef71e36333f1, content=<a href='/topic/show?id=451c55591a1' target=_blank style='color:#2F92EE;'>#抗穆勒激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55591, encryptionId=451c55591a1, topicName=抗穆勒激素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e734130559, createdName=xiay994464, createdTime=Fri Oct 23 21:00:35 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885175, encodeId=767e8851e5ec, content=<a href='/topic/show?id=9e7f26683a4' target=_blank style='color:#2F92EE;'>#体重#</a>与很多疾病都有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26683, encryptionId=9e7f26683a4, topicName=体重)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Sep 14 15:42:00 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807521, encodeId=761880e521b2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9055410320, createdName=ms5000000166877329, createdTime=Tue Aug 11 18:43:59 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806782, encodeId=f1b6806e82bb, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Aug 07 13:22:39 CST 2020, time=2020-08-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1777968, encodeId=8cab1e7796872, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Thu Dec 17 08:00:35 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063350, encodeId=81f6206335016, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Dec 29 08:00:35 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736333, encodeId=4ef71e36333f1, content=<a href='/topic/show?id=451c55591a1' target=_blank style='color:#2F92EE;'>#抗穆勒激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55591, encryptionId=451c55591a1, topicName=抗穆勒激素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e734130559, createdName=xiay994464, createdTime=Fri Oct 23 21:00:35 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885175, encodeId=767e8851e5ec, content=<a href='/topic/show?id=9e7f26683a4' target=_blank style='color:#2F92EE;'>#体重#</a>与很多疾病都有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26683, encryptionId=9e7f26683a4, topicName=体重)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Sep 14 15:42:00 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807521, encodeId=761880e521b2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9055410320, createdName=ms5000000166877329, createdTime=Tue Aug 11 18:43:59 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806782, encodeId=f1b6806e82bb, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Aug 07 13:22:39 CST 2020, time=2020-08-07, status=1, ipAttribution=)]
    2020-09-14 lovetcm

    #体重#与很多疾病都有关

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1777968, encodeId=8cab1e7796872, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Thu Dec 17 08:00:35 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063350, encodeId=81f6206335016, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Dec 29 08:00:35 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736333, encodeId=4ef71e36333f1, content=<a href='/topic/show?id=451c55591a1' target=_blank style='color:#2F92EE;'>#抗穆勒激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55591, encryptionId=451c55591a1, topicName=抗穆勒激素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e734130559, createdName=xiay994464, createdTime=Fri Oct 23 21:00:35 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885175, encodeId=767e8851e5ec, content=<a href='/topic/show?id=9e7f26683a4' target=_blank style='color:#2F92EE;'>#体重#</a>与很多疾病都有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26683, encryptionId=9e7f26683a4, topicName=体重)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Sep 14 15:42:00 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807521, encodeId=761880e521b2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9055410320, createdName=ms5000000166877329, createdTime=Tue Aug 11 18:43:59 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806782, encodeId=f1b6806e82bb, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Aug 07 13:22:39 CST 2020, time=2020-08-07, status=1, ipAttribution=)]
    2020-08-11 ms5000000166877329

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1777968, encodeId=8cab1e7796872, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Thu Dec 17 08:00:35 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063350, encodeId=81f6206335016, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Dec 29 08:00:35 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736333, encodeId=4ef71e36333f1, content=<a href='/topic/show?id=451c55591a1' target=_blank style='color:#2F92EE;'>#抗穆勒激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55591, encryptionId=451c55591a1, topicName=抗穆勒激素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e734130559, createdName=xiay994464, createdTime=Fri Oct 23 21:00:35 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885175, encodeId=767e8851e5ec, content=<a href='/topic/show?id=9e7f26683a4' target=_blank style='color:#2F92EE;'>#体重#</a>与很多疾病都有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26683, encryptionId=9e7f26683a4, topicName=体重)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Sep 14 15:42:00 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807521, encodeId=761880e521b2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9055410320, createdName=ms5000000166877329, createdTime=Tue Aug 11 18:43:59 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806782, encodeId=f1b6806e82bb, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Aug 07 13:22:39 CST 2020, time=2020-08-07, status=1, ipAttribution=)]
    2020-08-07 zb1235672

    学习了!

    0

相关资讯

JCEM:免疫检查点抑制剂诱导的甲状腺功能异常与体重指数有关

PD-1/L1抑制剂治疗的患者更有可能随着BMI的升高而发生甲状腺irAE,特别是甲状腺毒症。相比于较瘦患者,肥胖患者较早出现明显的甲状腺毒症。这些数据突显了接受免疫检查点抑制剂治疗的患者肥胖与免疫反

Open Rheumatol J:研究发现应将减肥纳入肥胖OA患者的治疗方案

与间歇性塞来昔布治疗相比,本研究旨在表征体重指数(BMI)对每日持续进行塞来昔布治疗的疗效。

Brit J Cancer:成年早期体重指数和体重增加与乳腺癌风险

只有在20岁时体重指数小于23.4 kg/m2的女性中,成年期体重增加才会增加绝经后患乳腺癌的风险。

JAMA Intern Med:健康的生活方式增加无重大慢性病年龄

各种健康的生活方式与无重大慢性病年龄增长有关

J Rheumatol:年龄、体重指数和体力活动引起的附着点改变:健康人群超声研究

在区分疾病与健康状态时,应当考虑到年龄、性别、BMI和体力活动对附着点的影响。

PLoS Med :抽烟减肥的说法不靠谱!烟民的肌肉实际上是“五花肉”

美国一项研究发现,与从不吸烟的人相比,吸烟者即使体重指数较低,其内脏脂肪及肌肉脂肪沉积的风险也较高。